{"id":"W2021777913","doi":"10.1016/j.ctrv.2011.12.002","title":"Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Sunnybrook Health Science Centre; Health Sciences Centre; MacEwan University","funders":"Alberta Health Services","keywords":"Medicine; Sunitinib; Pazopanib; Bevacizumab; Oncology; Clinical trial; Sorafenib; Breast cancer; Internal medicine; Adverse effect; Randomized controlled trial; Chemotherapy; Cancer; Angiogenesis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002355335,0.001175386,0.00558785,0.003116515,0.0002194916,0.001270298,0.001271757,0.001067517,0.003346439],"category_scores_gemma":[0.005212821,0.0005172677,0.003781304,0.003766661,0.0003439567,0.0009611886,0.0007108258,0.001122167,0.0003088659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009678948,"about_ca_system_score_gemma":0.00225818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00241853,"about_ca_topic_score_gemma":0.008613519,"domain_scores_codex":[0.9991388,0.0002320191,0.0002866504,0.0001113039,0.0001871985,0.00004390514],"domain_scores_gemma":[0.9970164,0.001989513,0.0006604078,0.00004073272,0.0002252182,0.00006778957],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001090171,0.00007660001,0.0005046927,0.592554,0.009287201,0.000134192,0.00008140338,0.0004559058,0.0009199477,0.0004621588,0.008999846,0.3854339],"study_design_scores_gemma":[0.003015935,0.00182916,0.009207023,0.4681309,0.1727004,0.001438047,0.0003257589,0.000503229,0.001186789,0.00175199,0.3397425,0.000168263],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001437853,0.999552,0.0000426344,0.00006966014,0.00003520471,0.00002007892,0.00005546476,0.000002498501,0.00007854847],"genre_scores_gemma":[0.00152648,0.9979234,0.0001901023,0.0001987029,0.00003511633,0.00002375888,0.0000469212,0.000001395074,0.00005411027],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00558785,"threshold_uncertainty_score":0.01245636,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.10315423392928,"score_gpt":0.3966961620687006,"score_spread":0.2935419281394205,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}